Firmenich is since May 9 2023 part of dsm-firmenich. Please follow us here: https://www.linkedin.com/company/dsm-firmenich

Innophos is a leading international producer of specialty ingredient solutions that deliver far-reaching, versatile benefits for the food, health, nutrition, and industrial markets. We leverage our expertise in the science and technology of blending and formulating phosphates and minerals to help our customers offer products that are tasty, healthy, and nutritious. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations across the United States, in Canada, Mexico, and China.

Elementis is a global specialty chemical company, with 1,300 employees operating 17 manufacturing sites across the globe. At Elementis, we bring a distinctive combination of expertise, innovation, and teamwork to every formulation challenge. We create high-value specialty additives that enhance the performance of our customers' products and make a positive change in the world. Combining our leading positions in the science of materials flow, surface modification, and formulation with access to unique natural materials, Elementis delivers unique chemistry, sustainable solutions to customers in a wide range of markets, including cosmetics, anti-perspirants, decorative and industrial coatings, automotive and ceramics. In 2022 Elementis reported revenue of $736m and adjusted operating profit of $101m.

PMC Group is a growth oriented, diversified, global chemicals company dedicated to innovative solutions to everyday needs in a broad range of end markets including plastics, consumer products, electronics, paints, packaging, personal care, food, automotive and pharmaceuticals. The Company was built on a sustainable model of growth through innovation while promoting social good. Dedicated to sustainability, PMC operates from a global manufacturing, innovation and marketing platform with facilities and personnel in the Americas, Europe and Asia. PMC Group began in 1994 as a vision in the mind of CEO Dr. P.M. Chakrabarti, then Chief Technical Officer of the Fortune 100 chemical powerhouse PPG Industries. The vision was to create a new model for the global corporation, one in which top line and bottom line growth go hand in hand, while promoting social good. The engine for this growth is the profits generated by the organization and the fuel for this engine is innovation. In order to foster innovation, our management structure strives to allow our businesses to operate in the manner most effective to serve their individual markets while having the financial, management and related strengths of global enterprise. Today, through a combination of innovative organic growth coupled with strategic acquisitions, PMC Group has become a global organization with manufacturing, research and marketing organizations throughout the world all fueled by continuous innovation and a dedication to unassailable quality, service and safety of our people and the environment. Our products enhance the quality of life of people in every corner of the globe. Our excitement for this growth has no bounds, and we continue to drive the innovation that has helped to make so many of our customers’ businesses better and helped create a better living for consumers around the world. We welcome your patronage in this journey of ours.

Renaissance is a US-based contract development and manufacturing organization (CDMO) for pharmaceutical and biotech companies. With over 20 years of experience in nasal sprays and sterile injectable dosage forms, we have an unparalleled track record of helping our clients from development through to commercial launch. Core Capabilities: - Aseptic fill-finish development and manufacturing (vials) - Unit-dose and bi-dose nasal spray development and manufacturing - Preserved and Non-preserved multi-dose nasal spray development and manufacturing - Analytical development & testing services - Spray characterization development & testing services - Formulation development & optimization - DEA Schedule I-V products From early-stage development through final production, Renaissance has the expertise and resources you need for success. Visit renpharm.com to learn more.

Plant Food Co. provides peace of mind to golf course superintendents and others through its liquid fertilizers and custom plant health solutions.

Palatin (NYSE American: PTN) is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin peptide receptor system. The melanocortin system is involved in regulating important physiological activities such as food intake and energy balance, desire and arousal, and the resolution of harmful inflammation. We are the first company to obtain FDA approval for a melanocortin based therapeutic, Vyleesi®, a treatment for women with hypoactive sexual desire disorder (HSDD). With the successful development of Vyleesi® and our extensive experience in the development of melanocortin based therapeutics, we are now focused on developing therapeutics that take advantage of the key role that the melanocortin system plays in the resolution of harmful inflammation. This has the potential to treat diseases that affect the eye, gastrointestinal system and the kidney. Our most advanced ocular product is PL9643, a topical treatment for dry eye disease, which is targeted to enter Phase 3 clinical trials in 2H 2021. We also have therapeutics in earlier stages of development for ophthalmic indications such as non-infectious uveitis, retinopathies and corneal diseases. Therapeutics that modulate the activity of the melanocortin system will have broad utility and to establish this, we are planning to conduct proof of concept clinical studies in ulcerative colitis and kidney disease. Vyleesi® is the first and only on-demand, FDA-approved treatment for premenopausal women suffering with HSDD, which affects 1 in 10 pre-menopausal women. Learn about this condition here: https://www.unblush.com/ To learn more about Vyleesi®, including Important Safety Information, visit here: https://www.vyleesi.com/ We are very excited by the tremendous potential our therapeutics have to positively impact the lives of patients and the value we can build for our shareholders. Find more information about our programs: www.palatin.com

Elementis is a global specialty chemical company, with 1,300 employees operating 17 manufacturing sites across the globe. At Elementis, we bring a distinctive combination of expertise, innovation, and teamwork to every formulation challenge. We create high-value specialty additives that enhance the performance of our customers' products and make a positive change in the world. Combining our leading positions in the science of materials flow, surface modification, and formulation with access to unique natural materials, Elementis delivers unique chemistry, sustainable solutions to customers in a wide range of markets, including cosmetics, anti-perspirants, decorative and industrial coatings, automotive and ceramics. In 2022 Elementis reported revenue of $736m and adjusted operating profit of $101m.

Founded in 1996 by former scientists working with leading pharmaceutical companies, AstaTech is one of earliest chemistry CRO companies in the United States and continues to grow. Today, we have more than 100 chemists (40% PH.D or MS degree level) and serve 10,000 customers worldwide. We offer over 100,000 advanced intermediates and drug-like building blocks. 10% of our products can be scaled up to kg / MT scales. By combing our chemistry expertise and our manufacturing capabilities, AstaTech delivers chemistry solution from drug discovery to manufacturing with high quality at competitive costs.

When the success of your clinical development program or drug product delivery is at stake, you can’t afford costly manufacturing delays. You deserve to work with a partner that puts your project — and you — first. It’s time to experience exceptional service. That’s the Experic difference. When you trust your project to Experic, you get a team of experts you can count on to deliver customized solutions that work for you. We specialize in advanced manufacturing, packaging and labeling technologies that accommodate a variety of dosing and packaging formats. With a 45,500-square-foot, state-of-the-art Class A research, manufacturing and packaging facility focused on powder filling and low-dose dry powder inhalation, we provide a hands-on, personalized approach to your development project that is backed by unparalleled industry experience and access to superior equipment solutions. Our approach is enhanced by our partnership with Harro Höfliger and use of its state-of-the-art filling equipment that offers extensive, cost-effective options for your program. • Powder blending and formulation development (inhalation (DPI) and oral solid) • Powder filling and low-dose powder filling technology • Precise filling capabilities with 100% high-speed check weighing • Encapsulation/over-encapsulation Find out more about our top-notch customer service and high-quality, on-time product delivery by visiting our website or emailing us at [email protected]. Experience It With Experic

At PMC Biogenix, renewable resources are at the core of our development, manufacturing and marketing of specialty chemicals. For over 50 years, we have prioritized innovation and client-need in our chemical products portfolio. PMC Biogenix chemical products are found as the basis for many other applications in a broad range of industries, including consumer and household care, crop protection, polymers and plastics, wire and cable and many other markets. As a global pioneer in the research and development and ultimately the manufacture of oleochemical derivatives, we aim to deliver product applications in nearly every chemical end market. PMC Biogenix chemists are available to assist you in deciding which of our products meet your specific needs. We invite you to contact us for product literature or any additional information you may need.

United Chemical Technologies was founded in Horsham, PA in 1986. Since then, UCT has evolved into a major competitor in the field of silica-based solid phase extraction. In October 1993, UCT acquired the specialty chemical branch of Huls America (Petrarch). This expansion into silane manufacturing allows for greater control over the chemical processes involved in producing our high-quality bonded phases. At UCT, we are committed to creating the highest quality products and distinguishing ourselves by the service, from salesperson to technical support, that we provide to every customer. As our company has grown over the past three decades, our solid phase product offerings have expanded as well. Every product that UCT makes, from columns to well plates, QuEChERS, polymeric based SPE, derivatizing reagents, GC liners, and manifolds are manufactured to the highest standards. We now offer hydrolyzing enzymes and HPLC Columns, and we have developed products for the cannabis industry that include pesticide and purity testing. Our diverse product offerings, dedicated staff, and loyal customers have made UCT what it is today. Now, we focus on the future and another successful 30 years!